She was educated at Canterbury Girls' Secondary College and University High School, Melbourne.
They initially chose to study the genetic component of immunity, discovering that antibody genes are a combination of pieces and can be arranged in a variety of ways.
This discovery helped explain the diversity of the immune system and its ability to fight a large array of harmful cell invaders.
[7] The caspases, a type of protease, remain inactive until signaled through a cascade to degrade the proteins that make up a cell.
[7] Cory's lab has developed Bcl2-blocking agents called BH3 mimetics, which, when paired with low-dose chemotherapy, have had positive results treating specific types of aggressive lymphomas.
Cory's work has been published in Blood, The EMBO Journal, Nature, Cell Death & Differentiation, and Proceedings of the National Academy of Sciences of the United States of America.